Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Iowa

117 recruiting clinical trials across 15 cities in Iowa (IA). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
117
Total Trials
117
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in Iowa

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT01860339

Child to Adult Neurodevelopment in Gene Expanded Huntington's Disease

Huntington's Disease (HD) is an autosomal dominant disease manifested in a triad of cognitive, psychiatric, and motor signs and symptoms. HD is caused by a triplet repeat...

Sponsor: Peggy C NopoulosEnrolling: 4006 locations
Huntington's Disease
RECRUITINGNCT01904851

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that...

Sponsor: Baylor Research InstituteEnrolling: 1400020 locations
Peripheral Arterial Disease
RECRUITINGNCT02012699

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal...

Sponsor: University of NebraskaEnrolling: 99999920 locations
Pancreatic CancerThyroid CancerLung Cancer+47
RECRUITINGPhase 4NCT02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in Veterans who have pre-diabetes and heart or blood...

Sponsor: VA Office of Research and DevelopmentEnrolling: 741020 locations
Prediabetic StateAtherosclerosisMetformin
RECRUITINGNCT03217110

Cerebellar Stimulation and Cognitive Control

The purpose of this study is to examine whether cerebellar stimulation can be used to improve cognitive deficits and mood in patients with schizophrenia, autism, bipolar disorder,...

Sponsor: Krystal Parker, PhDEnrolling: 2001 location
SchizophreniaAutism Spectrum DisorderBipolar Disorder+2
RECRUITINGPhase 2 / Phase 3NCT03373968

Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been previously treated in one...

Sponsor: ItalfarmacoEnrolling: 20620 locations
Duchenne Muscular Dystrophy
RECRUITINGNCT03694626

Objectively Diagnose and Monitor Treatment of Light Sensitivity

The purpose of this project is to provide a new framework for diagnosing and monitoring treatment of light sensitivity and headache by objective measurement of facial features,...

Sponsor: Randy KardonEnrolling: 1201 location
PhotophobiaTraumatic Brain InjuryMigraine
RECRUITINGNCT03858777

Cell Free DNA in Cardiac Sarcoidosis

Sarcoidosis is a multisystem granulomatous disease of unknown cause that can affect any organ in the body, including the heart. Granulomatous myocarditis can lead to ventricular...

Sponsor: Nabeel HamzehEnrolling: 1202 locations
Sarcoidosis With MyocarditisSarcoidosisHealthy+1
RECRUITINGPhase 1 / Phase 2NCT03947385

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

This is a Phase 1/2, multi-center, open-label basket study designed to evaluate the safety and anti-tumor activity of IDE196 in patients with solid tumors harboring GNAQ or GNA11...

Sponsor: IDEAYA BiosciencesEnrolling: 33615 locations
Metastatic Uveal MelanomaCutaneous MelanomaColorectal Cancer+1
RECRUITINGNCT03954899

Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging

The study will examine whether 5mg melatonin (over the counter, OTC) over a 9-month period improves Alzheimer's disease (AD) biomarkers and cognitive function in two groups of...

Sponsor: Natalie DenburgEnrolling: 2301 location
Mild Cognitive ImpairmentCognitive DeclineHealthy Aging
RECRUITINGNCT04071327

Pulmonary Hypertension Association Registry

The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects...

Sponsor: Pulmonary Hypertension Association, Inc.Enrolling: 300020 locations
Pulmonary Arterial HypertensionChronic Thromboembolic Pulmonary HypertensionPulmonary Hypertension
RECRUITINGNCT04134754

Carbon Dioxide (CO2) Chemosensitivity and SUDEP

The purpose of this research study is to better understand what causes Sudden Unexpected Death in Epilepsy (SUDEP). This study will enroll subjects from the University of Iowa...

Sponsor: University of IowaEnrolling: 3351 location
EpilepsySUDEP
RECRUITINGNCT04174157

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Spinal muscular atrophy (SMA) is a neurogenetic disorder caused by a loss or mutation in the survival motor neuron 1 gene (SMN1) on chromosome 5q13, which leads to reduced SMN...

Sponsor: Novartis PharmaceuticalsEnrolling: 70020 locations
Spinal Muscular Atrophy (SMA)
RECRUITINGNCT04202341

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Long-term, multicenter, multinational, observational, registry of patients with gMG that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion...

Sponsor: Alexion Pharmaceuticals, Inc.Enrolling: 50020 locations
Generalized Myasthenia Gravis
RECRUITINGNCT04278404

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of...

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults...

Sponsor: Duke UniversityEnrolling: 500020 locations
Coronavirus Infection (COVID-19)Pulmonary Arterial HypertensionUrinary Tract Infections in Children+22
RECRUITINGNCT04480918

University of Iowa Interventional Psychiatry Service Patient Registry

The purpose of this study is to examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Disorder (OCD). These...

Sponsor: Mark NiciuEnrolling: 10001 location
Treatment Resistant DepressionMajor Depressive EpisodeMajor Depression+4
RECRUITINGPhase 2NCT04504123

MMP-9 Inhibition for Recalcitrant Wet AMD

Wet (or neovascular) form of age-related macular degeneration (wAMD) is the most common cause of blindness in the Western world. Currently, anti-vascular endothelial growth factor...

Sponsor: University of IowaEnrolling: 501 location
Exudative Macular DegenerationWet Age-related Macular Degeneration
RECRUITINGNCT04509050

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their...

Sponsor: Sonya HeltsheEnrolling: 21020 locations
Cystic Fibrosis
RECRUITINGNCT04561518

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

The purpose of this study is to: * Describe epidemiological and clinical characteristics, natural history and real-world clinical management of ATTR amyloidosis patients *...

Sponsor: Alnylam PharmaceuticalsEnrolling: 150020 locations
Transthyretin-Mediated AmyloidosisATTR Amyloidosis
RECRUITINGNCT04855396

The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

There are no therapeutic agents that have been shown to improve outcomes from severe traumatic brain injury (TBI). Critical barriers to progress in developing treatments for...

Sponsor: University of MichiganEnrolling: 15011 locations
Traumatic Brain Injury
RECRUITINGPhase 1NCT04903119

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

This is a phase 1 dose-escalation study of nilotinib in combination with fixed-dose dabrafenib and trametinib regimen for patients with metastatic or unresectable melanoma...

Sponsor: Rina PlattnerEnrolling: 304 locations
Metastatic MelanomaBRAF Gene Mutation
RECRUITINGPhase 2NCT04919382

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung cancer that has spread to other places...

Sponsor: Dwight OwenEnrolling: 565 locations
Extensive Stage Lung Small Cell CarcinomaMetastatic Lung Small Cell CarcinomaRecurrent Lung Small Cell Carcinoma+3
RECRUITINGPhase 2 / Phase 3NCT04924322

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous...

Sponsor: Yale UniversityEnrolling: 25820 locations
Deep Venous Thrombosis
RECRUITINGPhase 1NCT04970901

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer...

The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin, glofitamab, or mosunetuzumab,...

Sponsor: Adc Therapeutics S.a.Enrolling: 20020 locations
B-Cell Non-Hodgkin LymphomaRelapsed B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma
RECRUITINGNCT04972604

CureDuchenne Link®: A Resource for Research

CureDuchenne link is a data hub comprised of integrated biospecimens, clinical data, and self- and/or caregiver-reported information from participants. Anyone over 4 weeks old who...

Sponsor: CureDuchenneEnrolling: 500010 locations
Duchenne Muscular DystrophyBecker Muscular Dystrophy
RECRUITINGNCT05033990

SPIROMICS Study of Early COPD Progression (SOURCE)

This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals. The study...

Sponsor: University of Massachusetts, WorcesterEnrolling: 100014 locations
COPD, Early-Onset
RECRUITINGNCT05040373

Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

The purpose of this study is to collect and evaluate pregnancy outcomes, pregnancy complications, and fetal/neonatal/infant outcomes in women exposed to patisiran-LNP.

Sponsor: Alnylam PharmaceuticalsEnrolling: 107 locations
Hereditary Transthyretin-mediated (hATTR) AmyloidosisPolyneuropathy
RECRUITINGNCT05057676

Autoimmune Intervention Mastery Course Study

The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically...

Sponsor: Terry L. WahlsEnrolling: 4001 location
Multiple SclerosisClinically Isolated SyndromeFibromyalgia+2
RECRUITINGPhase 2 / Phase 3NCT05076175

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative...

The purpose of this study is to evaluate the effectiveness and safety of ozanimod (RPC1063) in achieving and maintaining clinical remission. Ozanimod will be administered orally...

Sponsor: Bristol-Myers SquibbEnrolling: 12020 locations
Colitis, Ulcerative
RECRUITINGPhase 3NCT05145127

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab in participants who did not...

Sponsor: PfizerEnrolling: 24520 locations
Hemophilia AHemophilia B

Showing 30 of 117 trials in Iowa. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 117 clinical trials actively recruiting participants in Iowa. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Iowa include Breast Cancer, Cystic Fibrosis, Bipolar Disorder, Duchenne Muscular Dystrophy, Lung Cancer. Each has multiple active trials across research centers in the state.

Major trial sites in Iowa include Iowa City, Des Moines, Davenport, West Des Moines, Waterloo. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.